Anxiety Disorders Terminated Phase 2 Trials for Venlafaxine (DB00285)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00083980Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)Treatment